Adage Capital Partners Portfolio holdings
AUM
$59.3B
1-Year Return
26.26%
This Quarter Return
+15.42%
1 Year Return
+26.26%
3 Year Return
+130.73%
5 Year Return
+248.99%
10 Year Return
+658.76%
AUM
$52.9B
AUM Growth
+$4.64B
(+9.6%)
Cap. Flow
-$320M
Cap. Flow
% of AUM
-0.6%
Top 10 Holdings %
Top 10 Hldgs %
27.09%
Holding
978
New
135
Increased
352
Reduced
290
Closed
117
Top Buys
| 1 |
CSX Corp
CSX
|
$218M |
| 2 |
Merck
MRK
|
$195M |
| 3 |
HES
Hess
HES
|
$171M |
| 4 |
Lockheed Martin
LMT
|
$102M |
| 5 |
Amazon
AMZN
|
$90.8M |
Top Sells
| 1 |
Canadian Pacific Kansas City
CP
|
$231M |
| 2 |
Amgen
AMGN
|
$159M |
| 3 |
Honeywell
HON
|
$124M |
| 4 |
Domino's
DPZ
|
$124M |
| 5 |
Dover
DOV
|
$118M |
Sector Composition
| 1 | Technology | 26.41% |
| 2 | Healthcare | 17.14% |
| 3 | Financials | 11.03% |
| 4 | Consumer Discretionary | 9.77% |
| 5 | Industrials | 9.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
601
Paysafe
PSFE
$791M
| $9.76M | 0.02% |
618,001
-696,101
| -53% | -$11M |
|
602
Regency Centers
REG
$13.4B
| $9.76M | 0.02% |
161,100
+1,500
| +0.9% | +$90.8K |
|
603
Huntington Bancshares
HBAN
$26.1B
| $9.7M | 0.02% |
695,635
-711,100
| -51% | -$9.92M |
|
604
Noble Corp
NE
$4.58B
| $9.7M | 0.02% |
200,000
-123,584
| -38% | -$5.99M |
|
605
Huntington Ingalls Industries
HII
$10.6B
| $9.7M | 0.02% |
33,267
+200
| +0.6% | +$58.3K |
|
606
Third Coast Bancshares
TCBX
$560M
| $9.61M | 0.02% |
479,876
+46,849
| +11% | +$938K |
|
607
Digi International
DGII
$1.27B
| $9.58M | 0.02% |
+300,000
| New | +$9.58M |
|
608
Wynn Resorts
WYNN
$12.8B
| $9.56M | 0.02% |
93,500
+200
| +0.2% | +$20.4K |
|
609
Graphic Packaging
GPK
$6.19B
| $9.51M | 0.02% |
+325,953
| New | +$9.51M |
|
610
Wayfair
W
$10.7B
| $9.5M | 0.02% |
140,000
-385,000
| -73% | -$26.1M |
|
611
Invitation Homes
INVH
$18.6B
| $9.41M | 0.02% |
+264,200
| New | +$9.41M |
|
612
Scholar Rock
SRRK
$3.12B
| $9.32M | 0.02% |
525,000
-775,000
| -60% | -$13.8M |
|
613
Caesars Entertainment
CZR
$5.36B
| $9.26M | 0.02% |
211,600
+2,100
| +1% | +$91.9K |
|
|
LADR
614
Ladder Capital
LADR
$1.5B
| $9.18M | 0.02% |
+825,000
| New | +$9.18M |
|
615
Brown-Forman Class B
BF.B
$13.3B
| $9.15M | 0.02% |
177,332
-400
| -0.2% | -$20.6K |
|
616
Factset
FDS
$14B
| $9.04M | 0.02% |
19,900
-7,000
| -26% | -$3.18M |
|
617
Cogent Biosciences
COGT
$1.81B
| $8.96M | 0.02% |
+1,333,333
| New | +$8.96M |
|
618
Coherent
COHR
$14.9B
| $8.94M | 0.02% |
147,482
-245,000
| -62% | -$14.9M |
|
619
Dianthus Therapeutics
DNTH
$794M
| $8.94M | 0.02% |
+298,000
| New | +$8.94M |
|
620
Expeditors International
EXPD
$16.5B
| $8.8M | 0.02% |
+72,379
| New | +$8.8M |
|
621
Neurogene
NGNE
$280M
| $8.74M | 0.02% |
171,645
+36,064
| +27% | +$1.84M |
|
622
M&T Bank
MTB
$31.6B
| $8.72M | 0.02% |
59,947
-101,360
| -63% | -$14.7M |
|
623
C.H. Robinson
CHRW
$15.1B
| $8.71M | 0.02% |
114,400
+1,100
| +1% | +$83.8K |
|
624
Alight
ALIT
$2.02B
| $8.62M | 0.02% |
+875,000
| New | +$8.62M |
|
625
BridgeBio Pharma
BBIO
$9.91B
| $8.53M | 0.02% |
+276,000
| New | +$8.53M |
|